Congrats to @SMolholm & @EinsteinMed faculty for detailing how they navigated the pandemic challenges, including need to rapidly adjust study protocol,recruitment strategy, & in-person assessment battery to allow for virtual recruitment & data.
(4/4) Our @CNL_Einstein team would like to give a very special thank you to @aberrut1 for her contributions to the following commentary and to our lab. We wish you the very best in all your endeavors. Check out https://t.co/WPbs0A69IX to learn more. @RFK_I
Researchers describe how they handled disruptions to their clinical trial in autistic people brought on by the COVID-19 pandemic, and how these strategies might help in other situations. Via @BioMedCentral. #SpectrumSpotted https://t.co/bE9Bjj6syL
How researchers suspended & restarted their RCT of sensory integration therapy vs ABA-based intervention vs treatment as usual, for autistics aged 6-9 years https://t.co/p8eM7qGF7H NIH funded, trial started in 2015 with planned N=180, current planned N